ResearcherNanjing Drum Tower HospitalNo recent work listed

Jie Shao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9212-9685; OpenAlex author ID A5044549205. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. Co-author DOI 10.3389/fimmu.2022.799026 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Changchang Lu · 1 shared paper, 2022 · strength 0.14
- Paper Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. DOI 10.3389/fimmu.2022.799026 ↗
Juan Du · 1 shared paper, 2022 · strength 0.14
- Paper Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. DOI 10.3389/fimmu.2022.799026 ↗
Xin Qiu · 1 shared paper, 2022 · strength 0.14
- Paper Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. DOI 10.3389/fimmu.2022.799026 ↗
Baorui Liu · 1 shared paper, 2022 · strength 0.14
- Paper Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. DOI 10.3389/fimmu.2022.799026 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.